Looking at short term and long term growth drivers, Jon confirms that in the short term, we are seeing especially the B&S segment benefitting from the lifting of restrictions, as this segment is very reliant on “accidents” incurring in e.g. skiing, proving a direct example of the Alpine region, which he states in a normal year will see ~ 70.000 injuries a year, however during COVID they largely did not happen. In the long term, the growth drivers will be linked to the strategies presented at the CMD and tech-trade up to bionics, which he believes will grow more significantly post COVID as it requires more physical fittings etc. Furthermore, overall, the health economics continue to support the uptake in bionic prosthetics.
COVID impact not completely over, but outlook is solid
While COVID continue to have some negative impact on the business, e.g. increased freight costs, Jon confirms that the business is on the right track of getting back to a new normal, with share buyback reinstatement likely not far out in the future. He furthermore continues to see a strong, long-term outlook for the O&P market.
Aktuellt
SENASTE
